Adam Ackerman, MD, FACP
Medical Director, Accreditation and Regulatory AffairsAbout
Titles
Biography
When you or a loved one fall acutely ill and need the resources of a major academic hospital to come together to help, Dr. Adam Ackerman is there to step in. Dr. Ackerman specializes in the management of complex medical conditions warranting admission to the hospital. “I enjoy the challenge of diagnosing and treating severe illness while forming personal healing connections with patients and their families,” he says.
Ackerman joined Yale New Haven Hospital’s hospital medicine team in 2015 after serving as an active-duty physician in the United States Air Force. He received his MD from Tufts University School of Medicine in Boston, Massachusetts, where he was inducted into the Alpha Omega Alpha Medical Honor Society, and furthered his training with an internal medicine residency at the U.S. Air Force’s Keesler Medical Center in Biloxi, Mississippi.
An associate director of the hospital medicine team, Ackerman cares for patients at both the York Street and Saint Raphael campuses of Yale New Haven Hospital. He continues to lead quality improvement efforts in the areas of reducing repeat hospital admissions, improving length of stay, opioid stewardship, and ensuring safe patient flow through the system. He also remains active in research and in teaching internal medicine residents and students as an assistant clinical professor of internal medicine in the Yale School of Medicine.
Dr. Ackerman’s team employs advanced medical knowledge, experience, and technology to optimize accurate diagnosis and rapid treatment. “Our hospitalists specialize in delivering world-class care to our acutely ill patients, and when a particular problem requires collaboration with a subspecialist, the depth and breadth of expertise available to us at Yale is truly amazing,” he explains.
Dr. Ackerman is a fellow of the American College of Physicians.
Appointments
Internal Medicine
Assistant Clinical ProfessorPrimary
Other Departments & Organizations
Education & Training
- Residency
- Keesler Medical Center, 81st Medical Group, United States Air Force (2012)
- Internship
- Keesler Medical Center, 81st Medical Group, United States Air Force (2010)
- MD
- Tufts University School of Medicine (2009)
- MM
- Boston University College of Fine Arts, Conducting Performance (2003)
- AB
- The Florida State University, Music (2001)
Board Certifications
Internal Medicine
- Certification Organization
- AB of Internal Medicine
- Original Certification Date
- 2012
Research
Overview
Medical Subject Headings (MeSH)
Research at a Glance
Yale Co-Authors
Research Interests
Robert Fogerty, MD, MPH, SFHM
Analgesics, Opioid
Publications
Featured Publications
Association of an Opioid Standard of Practice Intervention With Intravenous Opioid Exposure in Hospitalized Patients
Ackerman AL, O’Connor P, Doyle DL, Marranca SM, Haight CL, Day CE, Fogerty RL. Association of an Opioid Standard of Practice Intervention With Intravenous Opioid Exposure in Hospitalized Patients. JAMA Internal Medicine 2018, 178: 759-763. PMID: 29799964, PMCID: PMC6145746, DOI: 10.1001/jamainternmed.2018.1044.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsOpioid exposureParenteral opioidsSubcutaneous routeOpioid dosesPain scoresHospitalized patientsIntervention groupIntravenous administrationDay 1Urban academic medical centerControl periodDoses of opioidsReduced opioid exposureEffective pain controlRate of patientsUse of opioidsDays of hospitalizationHospital day 1General medical unitIntravenous opioid useAcademic medical centerIntravenous opioidsOpioid routesOpioid therapySignificant postintervention
2011
Successful treatment of acute mania and perineal abscess using dexmedetomidine sedation as adjunctive therapy.
Ackerman AL, Mount C. Successful treatment of acute mania and perineal abscess using dexmedetomidine sedation as adjunctive therapy. BMJ Case Reports 2011, 2011 PMID: 22679158, PMCID: PMC3189658, DOI: 10.1136/bcr.07.2011.4543.Peer-Reviewed Original Research
2009
Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation.
Donaldson C, Eder S, Baker C, Aronovitz MJ, Weiss AD, Hall-Porter M, Wang F, Ackerman A, Karas RH, Molkentin JD, Patten RD. Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation. Circulation Research 2009, 104: 265-75, 11p following 275. PMID: 19074476, PMCID: PMC4427027, DOI: 10.1161/CIRCRESAHA.108.190397.Peer-Reviewed Original Research
Academic Achievements and Community Involvement
activity Chair
CommitteesOpioid Stewardship Committee, Yale New Haven HealthDetails2018 - Presentactivity Committee Member
CommitteesMortality Review Committee, Yale New Haven HospitalDetails2018 - Presentactivity Chair
CommitteesHospital Medicine Quality Improvement Committee, Yale New Haven HospitalDetails2019 - Presentactivity Member
CommitteesSystem Care Signature/Health Equity/Quality/Safety CommitteeDetails2019 - Presentactivity Member
CommitteesCommittee of Regulatory, Safety and QualityDetails2022 - Present
Links & Media
News
- May 22, 2020
Memorial Day Remembrance
- August 01, 2018Source: ACP Hospitalist
Success Story: Shifting opioids from IV to subcu
- May 15, 2018Source: Healthcare Finance
Why hospitals should take a good look at how opioids are being administered to patients
- May 14, 2018
Less is more when it comes to Rx opioids for hospital patients, study finds